Institutional Investors Weigh In On Marinus Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Institutional investors weigh in on marinus pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Institutional Investors Weigh In On Marinus Pharmaceuticals Today - Breaking & Trending Today

FY2027 EPS Estimates for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Lifted by Leerink Partnrs

FY2027 EPS Estimates for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Lifted by Leerink Partnrs
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Leerink Partnrs , Robertw Baird , China Universal Asset Management Co , Marinus Pharmaceuticals Company Profile , Marinus Pharmaceuticals , Royal Bank , Marinus Pharmaceuticals Inc , Sg Americas Securities , Institutional Investors Weigh In On Marinus Pharmaceuticals , Vanguard Group Inc , News Ratings For Marinus Pharmaceuticals Daily , Sherbrooke Park Advisers , Acuta Capital Partners , Cantor Fitzgerald , Marinus Pharmaceuticals Price Performance , Free Report , Marinus Pharmaceutical , Get Free Report , Universal Asset Management , Park Advisers , Capital Partners , Vanguard Group , Marinus Pharmaceuticals Daily ,

Marinus Pharmaceuticals (NASDAQ:MRNS) Rating Reiterated by Royal Bank of Canada

Royal Bank of Canada reaffirmed their sector perform rating on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a research note released on Monday morning, Marketbeat.com reports. Royal Bank of Canada currently has a $3.00 target price on the biopharmaceutical company’s stock, down from their prior target price of $24.00. Other equities analysts also […] ....

Marinus Pharmaceuticals Inc , Royal Bank , Nuveen Asset Management , Marinus Pharmaceuticals , Charles Schwab Investment Management Inc , Marinus Pharmaceuticals Stock Performance , News Ratings For Marinus Pharmaceuticals Daily , Tower Research Capital , Institutional Investors Weigh In On Marinus Pharmaceuticals , Deutsche Bank , Analyst Recommendations For Marinus Pharmaceuticals , Cantor Fitzgerald , Free Report , Get Free Report , Asset Management , Schwab Investment Management , Research Capital , Rhumbline Advisers , Marinus Pharmaceuticals Daily ,

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives $21.50 Consensus Price Target from Brokerages

Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. […] ....

Robertw Baird , Scott Braunstein , Steven Pfanstiel , Life Insurance Co , Securities Exchange Commission , Marinus Pharmaceuticals Inc , Marinus Pharmaceuticals Stock Performance , Royal Bank , Ameritas Investment Partners Inc , Marinus Pharmaceuticals , News Ratings For Marinus Pharmaceuticals Daily , Institutional Investors Weigh In On Marinus Pharmaceuticals , Cantor Fitzgerald , Analyst Recommendations For Marinus Pharmaceuticals , Marinus Pharmaceuticals Company Profile , Get Free Report , Marketbeat Ratings , Exchange Commission , Investment Partners , Jane Street Group , Get Free , Marinus Pharmaceuticals Daily , Nasdaq Mrns ,

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives $21.50 Average Price Target from Analysts

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives $21.50 Average Price Target from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Steven Pfanstiel , Scott Braunstein , Robertw Baird , Insider Transactions At Marinus Pharmaceuticals , Marinus Pharmaceuticals Stock Performance , Mirabella Financial Services , Institutional Investors Weigh In On Marinus Pharmaceuticals , Opaleye Management Inc , News Ratings For Marinus Pharmaceuticals Daily , Asset Management Inc , Marinus Pharmaceuticals , Denali Advisors , Marinus Pharmaceuticals Inc , Capital Corp , Analyst Recommendations For Marinus Pharmaceuticals , Royal Bank , Get Free Report , Asset Management , Financial Services , Get Free , Marinus Pharmaceuticals Daily ,

Marinus Pharmaceuticals (NASDAQ:MRNS) Price Target Increased to $15.50 by Analysts at LADENBURG THALM/SH SH

Marinus Pharmaceuticals (NASDAQ:MRNS) Price Target Increased to $15.50 by Analysts at LADENBURG THALM/SH SH
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Steven Pfanstiel , Robertw Baird , Scott Braunstein , Marinus Pharmaceuticals Company Profile , Marinus Pharmaceuticals , Wells Fargo Company , Marinus Pharmaceuticals Inc , Securities Exchange Commission , Royal Bank , News Ratings For Marinus Pharmaceuticals Daily , Marinus Pharmaceuticals Stock , Nuveen Asset Management , Insider Transactions At Marinus Pharmaceuticals , Institutional Investors Weigh In On Marinus Pharmaceuticals , Analyst Recommendations For Marinus Pharmaceuticals , Free Report , Moderate Buy , Get Free Report , Exchange Commission , State Teachers Retirement System , Asset Management , Marinus Pharmaceuticals Daily ,